Timothy Swartz
Rheumatology · Kalamazoo, MINPI 1851393797
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 399 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 15.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,995 and has fallen 97.8% since, to $44 in 2024.
Across 399 payments — averaging $14.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$893
- Amgen$752
- Johnson & Johnson$747
- Pfizer$493
- Novartis$464
- E.r. Squibb & Sons, L.L.C.$401
- plus $2K from 23 others
Across 4 payments — averaging $770.65 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$2K
- Pfizer$899
- Sanofi US Services Inc.$500
What the payments were for
- Food & beverage$5,606100%
- Education$140%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 59 | $893 |
| Amgen(2 entities) | 56 | $752 |
| Johnson & Johnson(2 entities) | 65 | $747 |
| Pfizer | 39 | $493 |
| Novartis | 32 | $464 |
| E.r. Squibb & Sons, L.L.C. | 29 | $401 |
| UCB, Inc. | 19 | $301 |
| Bristol Myers Squibb | 15 | $207 |
| Eisai Inc. | 8 | $175 |
| Collegium Pharmaceutical, Inc. | 10 | $163 |
| GSK | 7 | $140 |
| Almatica Pharma LLC | 3 | $117 |
| Genentech USA, Inc. | 19 | $116 |
| Radius Health, Inc. | 7 | $103 |
| Lilly USA, LLC | 8 | $103 |
| Boehringer Ingelheim | 3 | $54 |
| Nevro Corp. | 1 | $50 |
| Actelion Pharmaceuticals US, Inc. | 2 | $48 |
| Vertical Pharmaceuticals, LLC | 3 | $45 |
| Abbott | 1 | $44 |
| Tersera Therapeutics LLC | 2 | $38 |
| Antares Pharma, Inc. | 2 | $36 |
| Ultragenyx Pharmaceutical Inc. | 2 | $34 |
| Daiichi Sankyo Inc. | 2 | $26 |
| AstraZeneca | 1 | $15 |
| Boston Scientific | 1 | $14 |
| IBSA Pharma Inc. | 1 | $13 |
| Bioventus LLC | 1 | $13 |
| Arbor Pharmaceuticals, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Otezla$109
How this compares
$5,620 in reported general payments places this provider in the 60th percentile of 195 rheumatology providers in Michigan.
Other rheumatology in Kalamazoo
- Amar MajjhooSaint Clair Shores$1.8M
- Andrew SulichSaint Clair Shores$1.7M
- Dinesh KhannaAnn Arbor$1.2M
- Roman CzubatyjRochester Hills$764K
- Delfin SantosRochester$242K
- Allan MortonWarren$229K
- Elena SchiopuAnn Arbor$180K
- Alireza MeysamiNovi$170K
- Fazleomar MahmoodChelsea$167K
- Barakat ThabetGrand Rapids$128K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.